These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8250344)

  • 1. Experimental AIDS drug, d4T, now available to patients in critical need.
    Ann Allergy; 1993 Nov; 71(5):A-27. PubMed ID: 8250344
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental AIDS drug, d4T, now available to patients in critical need.
    Ann Allergy; 1993 Apr; 70(4):A19. PubMed ID: 8385427
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental AIDS drug d4T, now available to patients in critical need.
    Ann Allergy; 1993 Sep; 71(3):A24. PubMed ID: 8396862
    [No Abstract]   [Full Text] [Related]  

  • 4. Stavudine (d4T) for HIV.
    Am Pharm; 1994 Aug; NS34(8):9. PubMed ID: 7942505
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA approves AIDS drug.
    Am Pharm; 1992 Sep; NS32(9):13-4. PubMed ID: 1332462
    [No Abstract]   [Full Text] [Related]  

  • 6. Committee recommends approval of AIDS drug.
    Minn Med; 1994 Jul; 77(7):55. PubMed ID: 8052209
    [No Abstract]   [Full Text] [Related]  

  • 7. d4T+AZT--unexpected CD4 drop seen in study.
    AIDS Treat News; 1996 Dec; (No 261):1. PubMed ID: 11364024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS drugs in development. Facts and comparisons.
    Hosp Pharm; 1993 Feb; 28(2):161, 165-7. PubMed ID: 10125704
    [No Abstract]   [Full Text] [Related]  

  • 9. Expanded access for experimental AIDS drugs.
    Barr D; Gilden D
    GMHC Treat Issues; 1995 Sep; 9(9):2. PubMed ID: 11362908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D4T: new clinical data confirms benefit.
    James JS
    AIDS Treat News; 1995 May; (no 222):1-3. PubMed ID: 11362460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fast track toward new AIDS drugs.
    Long K; Long R
    Nurse Pract Forum; 1991 Jun; 2(2):80-1. PubMed ID: 1840952
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA antiviral advisory hearings on lamivudine (Epivir, 3TC), saquinavir (Invirase), stavudine (Zerit, d4T), November 6-8. Food and Drug Administration.
    AIDS Treat News; 1995 Oct; (no 233):4-5. PubMed ID: 11363038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Row over controversial new AIDS drug.
    Buderi R
    Nature; 1989 Sep; 341(6240):267. PubMed ID: 2677738
    [No Abstract]   [Full Text] [Related]  

  • 14. Combining d4T/ddI looks promising.
    Posit Aware; 1996; 7(1):7. PubMed ID: 11363129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [AIDS studies with didanosine and stavudine].
    Dtsch Med Wochenschr; 1996 May; 121(22):A30. PubMed ID: 8646981
    [No Abstract]   [Full Text] [Related]  

  • 16. Virodene down but not out.
    Jones JS
    S Afr Med J; 1999 Feb; 89(2):116, 118. PubMed ID: 10191855
    [No Abstract]   [Full Text] [Related]  

  • 17. 124 drugs currently in development.
    AIDS Patient Care STDS; 1998 Feb; 12(2):149. PubMed ID: 11361916
    [No Abstract]   [Full Text] [Related]  

  • 18. Stavudine made available under parallel track policy.
    Clin Pharm; 1993 Jan; 12(1):7. PubMed ID: 8381342
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA triple header. Food and Drug Administration.
    Smart T
    GMHC Treat Issues; 1995 Nov; 9(11):1-3. PubMed ID: 11362986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fumes from the spleen.
    Paediatr Perinat Epidemiol; 1991 Jul; 5(3):258-60. PubMed ID: 1881836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.